An overview of phage therapy as an alternative option of MDR bacteria and possible future of COVID-19 treatment
| bracu.degree.level | Postgraduate | |
| bracu.type.group | Student Works | |
| datacite.rights | Open Access | |
| dc.contributor.advisor | Naser, Iftekhar Bin | |
| dc.contributor.author | Fatema, Naima | |
| dc.contributor.department | Department of Mathematics and Natural Sciences | |
| dc.date.accessioned | 2024-09-24T05:47:44Z | |
| dc.date.available | 2024-09-24T05:47:44Z | |
| dc.date.copyright | 2022 | |
| dc.date.issued | 2022-09 | |
| dc.description | This thesis submitted to the Department of Mathematics and Natural Sciences in partial fulfillment of the requirements for the degree of Master of Science in Biotechnology, 2022. | en_US |
| dc.description | Cataloged from PDF version of thesis. | |
| dc.description | Includes bibliographical references (pages 31-35). | |
| dc.description.abstract | One of the greatest difficulties that humanity will confront in the near future is antibiotic resistance. (Bacterio) phage therapy is a valuable therapeutic alternative to antibiotics, and while the concept is almost as ancient as phage discovery, antibiotic discovery and development in the mid-twentieth century hampered its widespread adoption. The global problem of multidrug-resistant bacterial infections demand immediate action, including the invention of antibiotic-free medicines. Phages can down regulate excessive inflammatory reactions relevant in clinical course of COVID-19. This paper is focused on the existing regulatory framework to which such therapy should adhere and reviewed the current obstacles and shortcomings in scientific development for bacteriophage therapy and assume that the PT may participate a therapeutic role in terms of COVID-19 treatment. | en_US |
| dc.description.degree | Master of Science in Biotechnology | |
| dc.description.statementofresponsibility | Naima Fatema | |
| dc.format.extent | 35 pages | |
| dc.identifier.other | ID 21176004 | |
| dc.identifier.uri | http://hdl.handle.net/10361/24173 | |
| dc.language.iso | en | en_US |
| dc.publisher | BRAC University | en_US |
| dc.rights | Brac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. | |
| dc.subject | Covid-19 | en_US |
| dc.subject | MDR bacteria | en_US |
| dc.subject | Phage therapy | en_US |
| dc.subject.lcsh | Covid-19--Treatment | |
| dc.title | An overview of phage therapy as an alternative option of MDR bacteria and possible future of COVID-19 treatment | en_US |
| dc.type | Thesis | en_US |